Skip to main content

Advertisement

Table 5 Number of patients experiencing common adverse Events (>1% of Population)

From: Efficacy and safety of single injection of cross-linked sodium hyaluronate vs. three injections of high molecular weight sodium hyaluronate for osteoarthritis of the knee: a double-blind, randomized, multi-center, non-inferiority study

Preferred Term HMWHA XLHA
N = 146 (%) N = 139 (%)
Diarrhoea 3 (2.1) 1 (0.7)
Dyspepsia 1 (0.7) 2 (1.4)
Injection site pruritus 2 (1.4) 1 (0.7)
Pain 1 (0.7) 4 (2.9)
Pyrexia 0 (0) 3 (2.2)
Cystitis 2 (1.4) 2 (1.4)
Nasopharyngitis 3 (2.1) 7 (5)
Upper respiratory tract infection 0 (0) 3 (2.2)
Joint swelling 0 (0) 2 (1.4)
Musculoskeletal pain 0 (0) 2 (1.4)
Pain in extremity 6 (4.1) 3 (2.2)
Plantar fasciitis 0 (0) 2 (1.4)
Headache 5 (3.4) 1 (0.7)
Paraesthesia 0 (0) 2 (1.4)
Cough 3 (2.1) 0 (0)
Erythema 0 (0) 2 (1.4)